AU4796393A - Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen - Google Patents

Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen

Info

Publication number
AU4796393A
AU4796393A AU47963/93A AU4796393A AU4796393A AU 4796393 A AU4796393 A AU 4796393A AU 47963/93 A AU47963/93 A AU 47963/93A AU 4796393 A AU4796393 A AU 4796393A AU 4796393 A AU4796393 A AU 4796393A
Authority
AU
Australia
Prior art keywords
antigens
antibodies
rheumatoid arthritis
sensitive assay
identify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47963/93A
Inventor
Roland W. E Buelow
Cohava Gelber
Thomas J Powell
Wim C. A Van Schooten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immulogic Pharmaceutical Corp
Original Assignee
Immulogic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharmaceutical Corp filed Critical Immulogic Pharmaceutical Corp
Publication of AU4796393A publication Critical patent/AU4796393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU47963/93A 1992-07-31 1993-07-30 Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen Abandoned AU4796393A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92314392A 1992-07-31 1992-07-31
US923143 1992-07-31
US98747292A 1992-12-04 1992-12-04
US987472 1992-12-04
PCT/US1993/007218 WO1994003478A1 (en) 1992-07-31 1993-07-30 Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen

Publications (1)

Publication Number Publication Date
AU4796393A true AU4796393A (en) 1994-03-03

Family

ID=27129862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47963/93A Abandoned AU4796393A (en) 1992-07-31 1993-07-30 Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen

Country Status (2)

Country Link
AU (1) AU4796393A (en)
WO (1) WO1994003478A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1600897A (en) * 1996-02-06 1997-08-28 Reinhard Pelzer Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system
ATE412175T1 (en) 1996-03-21 2008-11-15 Circassia Ltd USE OF CRYPTIC PEPTIDES TO INDUCE IMMUNOLOGICAL TOLERANCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
NL8703107A (en) * 1987-12-22 1989-07-17 Nederlanden Staat POLYPEPTIDES AND DERIVATIVES THEREOF, AND THEIR USE THEREOF IN PHARMACEUTICAL AND DIAGNOSTIC PREPARATIONS.
US5021342A (en) * 1988-06-30 1991-06-04 University Hospitals Of Cleveland Expression cDNA clones encoding antigens of onchocerca volvulus
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
WO1994003478A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
EP0197435A3 (en) Choriocarcinoma monoclonal antibodies and antibody panels
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
ZA855031B (en) Assay for simultaneous detection of antigen and antibody in given serum
IL127764A0 (en) Purified sperm surface antigen monoclonal antibody therefor and applications thereof
AU7345487A (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
EP0405578A3 (en) Enzyme immunoassay for antigen and solid phase used therefor
AU7473087A (en) Apparatus for immunoassay with antibody or antigen attached to walls
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3696289A (en) Anti-fc assay for detection of antibodies
AU1538392A (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
AU4476693A (en) Indirect chromatographic antigen sandwich test for detection of specific antibody and device therefor
AU6220096A (en) Method for the simultaneous detection of different antibodies and/or antigens
AU9052491A (en) Assay device and method for antibody and antigen detection
AU5444386A (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
AU3752595A (en) Method and device for determination of proteins employing antigen/antibody reactions
AU8944291A (en) Immunoassay for the determination of anti-hiv antibodies in human samples
AU1334588A (en) Assay for detecting hepatitis antigens and aids antibodies
AU4476593A (en) Chromatographic antigen sandwich test for detection of specific antibody and device therefor
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
AU4796393A (en) Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen
IL78148A0 (en) Assay for antigens and antibodies and methods and device for carrying out thereof
GB9710875D0 (en) Assay for detecting HIV antigens and HIV antibodies